Variant Bio
Variant Bio develops therapies by studying the genes of people with exceptional health-related traits. It uses insights from human genetics to inform drug discovery and development, aiming to improve global health while prioritizing ethical partnerships and benefit-sharing with participating communities.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2018
- Employees
- 38
- Stage
- startup
- Members see funding amounts. .
- Founders
- Stephane Castel, PhD
Is this your organization? Claim it
Members see Variant Bio's funding rounds, amounts and investors.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
Stephane Castel Founder, Chief Technology Officer & Chief Scientific Officer
-
Andrew Farnum Executive, Chief Executive Officer
-
Craig Basson Executive, Chief Medical Officer, President of R&D